Neurological, Neuromuscular, and Autonomic Manifestations of COVID-19: A Retrospective Study

When a virus like SARS-CoV-2 enters the body, it does not always stop at the lungs. In many people, the infection triggers a cascade of effects that reach the nervous system, causing problems that persist long after the initial illness has passed. This collection of lingering symptoms is often called Long COVID, a condition where the body continues to struggle with fatigue, brain fog, and physical weakness months after the acute infection. The nervous system, which controls everything from our heartbeat to our ability to move a muscle, can be attacked in several different ways. Sometimes the blood vessels in the brain become blocked or bleed; other times, the nerves that control muscles fail to send signals correctly; and in yet other cases, the automatic systems that regulate heart rate and blood pressure go haywire. Understanding exactly how the virus damages these different parts of the nervous system is crucial, because the treatment for a blocked blood vessel is very different from the treatment for a nerve that has stopped working.

A team of researchers at Cleveland Clinic Florida set out to map these distinct patterns in a group of seventy-two adults who had been infected with the virus and were experiencing neurological issues. They did not look at the patients as a single, mixed group. Instead, they sorted them into three specific categories based on what was hurting the most: those with blood vessel problems in the brain, those with nerve and muscle failures, and those with automatic system malfunctions. By comparing these groups side by side, the researchers could see who was most likely to get sick, what their bodies looked like under testing, and how severe their outcomes were. The goal was to move beyond a general list of symptoms and find the specific fingerprints the virus leaves on different parts of the nervous system.

The study revealed that these three groups of patients were remarkably different from one another, almost as if the virus was targeting them with different strategies. The patients with blood vessel problems in the brain were the oldest, with an average age of nearly seventy years, and they were mostly men. They also had the highest rates of heart disease. In contrast, the group with automatic system failures was the youngest, averaging forty-six years old, and was made up mostly of women. The group with nerve and muscle problems fell somewhere in the middle in terms of age but stood out for one specific reason: almost everyone in this group had not been vaccinated against the virus. This was a striking difference, as the other two groups had many vaccinated individuals. The researchers noted that the patients with nerve and muscle issues also stayed in the hospital the longest, averaging nineteen days, compared to just three or four days for the other groups.

When the doctors looked inside the bodies of these patients, the differences became even clearer. For the patients with blood vessel issues, the most common problem was a stroke caused by a clot, which occurred in nearly eighty percent of cases. About half of these strokes happened in the middle of the brain, and in many cases, the cause could not be pinned down to a traditional risk factor like high blood pressure or a blocked artery. This suggests the virus itself may be creating a sticky, clot-prone environment in the blood. The patients who died in the study all belonged to this blood vessel group. They were older, had much higher levels of a blood marker called D-dimer, which indicates clotting activity, and suffered from strokes that affected both sides of the brain. Their condition was severe enough that their disability scores at the time of discharge were at the highest possible level.

The patients with nerve and muscle problems showed a different kind of damage. When doctors tested the electrical activity of their muscles and nerves, the results were abnormal in more than eighty percent of cases. This pattern of electrical failure often points to conditions where the immune system attacks the nerves that control movement, similar to a condition known as Guillain-Barré syndrome. The fact that nearly all of these patients were unvaccinated suggests that the vaccine might offer protection against this specific type of severe nerve damage, though the researchers noted that more studies are needed to confirm this link. The brain scans of these patients often showed signs of inflammation, and their spinal imaging frequently revealed abnormalities, indicating that the virus was causing widespread irritation in the nervous system.

The third group, those with automatic system failures, presented a picture of a body that had lost its ability to regulate itself. These patients, mostly younger women, often felt dizzy or lightheaded when they stood up. Tests confirmed that many of them had a condition where their heart rate spikes too high upon standing, a disorder known as postural orthostatic tachycardia syndrome. Other tests showed that the tiny nerves that control sweating were damaged in a pattern that started at the feet and moved upward, a sign of small fiber neuropathy. Unlike the other groups, their brain scans were almost entirely normal, suggesting that the problem was not in the brain itself but in the peripheral nerves that connect the brain to the rest of the body. This group represented the largest portion of the study, highlighting how common these automatic system failures have become in the wake of the pandemic.

The researchers concluded that the virus does not cause a single, uniform type of neurological damage. Instead, it creates distinct profiles depending on the patient's age, sex, and vaccination status. The older, unvaccinated men were most at risk for severe blood clots and strokes, while the younger, unvaccinated women were more likely to suffer from automatic system failures. The unvaccinated patients with nerve and muscle issues faced the longest and most difficult recoveries. The study also found that high levels of clotting markers in the blood were a strong warning sign for death in patients with strokes. While the study was limited by its small size and the fact that it looked back at records rather than following patients forward in time, the findings provide a clearer picture of the different ways the virus attacks the nervous system. This clarity is essential for doctors, as it helps them understand that a one-size-fits-all approach to Long COVID will not work; instead, treatment must be tailored to the specific type of neurological damage a patient is experiencing.